Modification of Ha-ras Oncogene p21 Expression and Cell Cycle Progression in the Human Colonic Cancer Cell Line HT-29

Cancer Research

Volumn 47, Issue 11, 1987, Pages 2826-2830

  Czemiak, Boedan ^a   Herz, Fritz ^b   Wersto, Robert P ^b   Koss, Leopold G ^b  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE; CELL CYCLE G1 PHASE; COLON CANCER; PRIORITY JOURNAL;

BUTYRIC ACID; BUTYRIC ACIDS; CELL CYCLE; CELL LINE; COLONIC NEOPLASMS; DNA, NEOPLASM; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GTP-BINDING PROTEINS; HUMAN; ONCOGENES; OSMOLAR CONCENTRATION; PREDNISOLONE; PROTO-ONCOGENE PROTEINS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023214006     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Shih, T. Y., and Weeks, M. O. Oncogenes and cancer the p21 ras genes. Cancer Invest., 2: 109-123, 1984.
2. Weinberg, R. A. The action of oncogenes in the cytoplasm and nucleus. Science (Wash. DC), 230: 770-776, 1985.
3. Feramisco, J. R., Gross, M., Kamata, T., Rosenberg, M., and Sweet, R. W. Microinjection of the oncogene form of the human Ha-ras (T-24) protein results in rapid proliferation of quiescent cells. Cell, 38: 109-117, 1984.
4. Mulcahy, L. S., Smith, M. R., and Stacey, D. W. Requirement for ras protooncogene function during serum-stimulated growth of NIH 3T3 cells. Nature (Lond.), 313: 241-243, 1985.
5. 1transit induced by The mitogenic-oncogenic viral Ki-ras gene product. Mol. Cell. Biol., 6: 1386-1392, 1986.
6. Durkin, J. P., and Whitfield, J. F. The viral Ki-ras gene must be expressed in the G3 phase if ts Kirsten sarcoma virus-infected NRK cells are to proliferate in serum-free medium. Mol. Cell. Biol., 7: 444-449, 1987.
7. Herz, F., Miller, O. J., Miller, D. A., Auersperg, N., and Koss, L. G. Chromosome analysis and alkaline phosphatase of C4I, a cell line of human cervical origin distinct from HeLa. Cancer Res., 37: 3209-3213, 1977.
8. Herz, F., Barlebo, H., and Koss, L. G. Modulation of alkaline phosphatase activity in cell cultures derived from human urinary bladder carcinoma. Cancer Res., 34: 1943-1946, 1974.
9. Herz, F., Schermer, A., Halwer, M., and Bogart, L. H. Alkaline phosphatase in HT-29, a human colon cancer cell line: influence of sodium butyrate and hyperosmolality. Arch. Biochem. Biophys., 210: 581-591, 1981.
10. Czerniak, B., Darzynkiewicz, Z., Staiano-Coico, L., Herz, F., and Koss, L. G. Expression of Ca antigen in relation to cell cycle in cultured human tumor cells. Cancer Res., 44:4342-4346, 1984.
11. Genes Perucho, M., Goldfarb, M., Shimizu, K., Lama, C., Fogh, J., and Wigler, M. Human-tumor-derived cell lines contain common and different transforming Cell, 27: 467-476, 1981.
12. Finkel, T., Der, C. J., and Cooper, G. M. Activation of ras genes in human tumors does not affect localization, modification, or nucleotide binding properties of p 21. Cell, 37: 151-158, 1984.
13. kgenes in human lung and colon carcinomas. Cell, 32: 201-208, 1983.
14. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193: 265-275, 1951.
15. Clevenger, C. F., Bauer, K. D., and Epstein, A. L. A method for simultaneous nuclear immunofluorescence and DNA content quantitation using monoclonal antibodies and flow cytometry. Cytometry, 6: 208-214, 1985.
16. Tanaka, T., Slamon, D. J., and Cline, M. J. Efficient generation of antibodies to oncoproteins by using synthetic peptide antigens. Proc. Natl. Acad. Sci. USA, 82:3400-3404, 1984.
17. Hap21 in normal and neoplastic cells in fixed tissue sections from Harvey sarcoma virus-infected mice. Carcinogenesis (Lond.), 7: 645-651, 1986.
18. Tahara, E., Yasui, W., Taniyama, K., Ochiai, A., Yamamoto, T., Nakajo, S., and Yamamoto, M. Ha-ras oncogene product in human gastric carcinoma: correlation with invasiveness, metastasis, or prognosis. Gann, 77: 517–522, 1986.
19. Latt, S. A. Fluorescent probes of DNA microstructure and synthesis. In: M. R. Melamed, P. F. Mullaney, and M. L. Mendelsohn (eds.), Flow Cytometry and Sorting, pp. 262–284. New York: John Wiley and Sons, 1979.
20. Kaczmarek, L. Protooncogene expression during the cell cycle. Lab. Invest, 54: 365-376, 1986.
21. Goyette, M., Petropoulos, C. J., Shank, P. R., and Fausto, N. Expression of a cellular oncogene during liver regeneration. Science (Wash. DC), 219: 510-512, 1983.
22. Goyette, M., Petropoulos, C. J., Shank, P. R., and Fausto, N. Regulated transcription of c-Ki-ras and c-myc during compensatory growth of rat liver. Mol. Cell. Biol., 4: 1493-1498, 1984.
23. Campisi, J., Gray, H. E., Pardee, A. B., Dean, M., and Sonenshein, G. E. Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation. Cell, 36: 241-247, 1984.
24. Kelly, K., Cochran, B. H., Stiles, C. D., and Leder, P. Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell, 35: 603-610, 1983.
25. Greenberg, M. E., and Ziff, E. B. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature (Lond.), 311: 433-438, 1984.
26. Kruijer, W., Cooper, J. A., Hunter, T., and Verma, I. M. Platelet-derived growth factor induces rapid but transient expression of c-fos gene and protein. Nature (Lond.), 312: 711-716, 1984.
27. Muller, R., Bravo, R., Burckhardt, J., and Curran, T. Induction of c-fos gene and protein by growth factors precedes activation of c-myc. Nature (Lond.), 312: 716-720, 1984.
28. Riffling, S. R., Gibson, C. W., Ferrari, S., and Baserga, R. The effect of cycloheximide on the expression of cell cycle dependent genes. Biochem. Biophys. Res. Commun., 132: 327-335, 1985.
29. Stacey, D. W., and Kung, H-F. Transformation of NIH-3T3 cells by microinjection of Ha-ras p21 protein. Nature (Lond.), 310: 508-511, 1984.
30. Feramisco, J. R., Clark, R., Wong, G., Arnheim, N., Milley, R., and McCormick, F. Transient reversion of ras oncogene-induced cell transformation by antibodies specific for amino acid 12 of ras protein. Nature (Lond.), 314: 639-642, 1985.
31. Hagag, N., Halegoua, S., and Viola, M. Inhibition of growth factor-induced differentiation of PC12 cells by microinjection of antibody to ras p21. Nature (Lond.), 319: 680-682, 1986.
32. Horan Hand, P., Thor, A., Wunderlich, D., Caruso, A., and Schlom, J. Monoclonal antibodies of predefined specificity detect activated ras gene expression in human mammary and colon carcinomas. Proc. Natl. Acad. Sci. USA, 81: 5227-5231, 1984.
33. Thor, A., Horan Hand, P., Wunderlich, D., Caruso, A., Muraro, R., and Schlom, J. Monoclonal antibodies define different ras gene expression in malignant and benign colonic disease. Nature (Lond.), 311: 562-565, 1984.
34. Viola, M. V., Fromowitz, F., Oravez, S., Deb, S., and Schlom, J. ras Oncogene p21 Expression is increased in premalignant lesions and high grade bladder carcinomas. J. Exp. Med., 161: 1213-1218, 1985.
35. Viola, M. V., Fromowitz, F., Oravez, S., Deb, S., Finkel, G., Lundy, J., Horan Hand, P., Thor, A., and Schlom, J. Expression of ras oncogene p21 in prostate cancer. New Eng. J. Med., 314: 133-137, 1986.
36. Huang, A. L., Ostrowski, M. C., Berard, D., and Hager, G. L. Glucocorticoid regulation of the Ha-MuSV p21 gene conferred by sequences from mouse mammary tumor virus. Cell, 27: 245-255, 1981.
37. Najam, N., Clair, T., Bassin, R. H., and Cho-Chung, Y. S. Cyclic AMP suppresses expression of Ha-ras Oncogene linked to the mouse mammary tumor virus promoter. Biochem. Biophys. Res. Commun., 134: 436–442, 1986.
38. Honcogene in mammary carcinomas in rats. Biochem. Biophys. Res. Commun., 123: 141-147, 1984.
39. Eastman-Reks, S. B., and Vedeckis, W. V. Glucocorticoid inhibition of c-myc, c-myb, and c-Ki-ras expression in a mouse lymphoma cell line. Cancer Res., 46: 2457-2462, 1986.
40. Kruh, J. Effects of sodium-butyrate, a new pharamacological agent, on cells in culture. Mol. Cell. Biochem., 42: 65-82, 1982.
41. 1phase of the cell cycle. J. Cell Sci., 51: 163-172, 1981.
42. Cook, J. R., Schwartz, C. E., Fausel, E. D., and Chiu, J-F. Effect of sodium butyrate on a-fetoprotein expression in rat hepatoma cells in vitro. Cancer Res., 45: 3215-3219, 1985.
43. Flatow, U., Willingham, M.C., and Rabson, A. S. Butyrate prevents Harvey sarcoma-virus focus formation but permits oncogene expression. Cancer Lett., 22: 203-210, 1984.
44. Yamaguchi, Y., Kluge, N., Ostertag, W., and Furusawa, W. Erythyroid differentiation and commitment in rat erythroleukemia cells with hypertonic culture conditions. Proc. Natl. Acad. Sci. USA, 78: 2325-2329, 1981.
45. Ray, A., Walden, W. E., Brendler, T., Zenger, V. E., and Thach, R. E. Effect of medium hypertonicity on reovirus translation rates. An application of kinetic modeling in vivo. Biochemistry, 24: 7525-7532, 1985.
46. Robertson, M. C., and Bermek, E. Studies of the protein synthetic activity of lysates from HeLa cells incubated in hypertonic medium. Biochim. Biophys. Acta, 476: 88-95, 1977.
47. Pawlowski, P. J. Differential effect of hypertonic initiation block on the synthesis of collagen chains by cultured chick embryo cells. Biochemistry, 21: 34-38, 1982.
48. Schachtschabel, D.O. Increase in adenosine triphosphatase activity of Ehrlich ascites tumor cells following serial cultivation in media with increased (hypertonic) NaCl content. Z. Naturforsch., 27b: 840–842, 1972.
49. Bolognani, L., Bolognani Fantin, A. M., Castellana, C., Fuhrman Conti, A. M., Giuliani, A., Sabatini, M. A., Sanguini, C. L., Silvestri, M. G., and Tricoli, S. Enzymatic characterization of E.U.E. (embryonal human explants) cells adapted to hypertonic media. Acta Histochem., 76: 1–11, 1985.
50. Noda, M., Selinger, Z., Scolnick, E. M., and Bassin, R. H. Flat revertants isolated from Kirsten sarcoma virus-transformed cells are resistant to the action of specific oncogenes. Proc. Natl. Acad. Sci. USA, 80: 5602–5606, 1983.
51. Bassin, R. H., Noda, M., Scolnick, E. M., and Selinger, Z. S. Study of possible relationships among retroviral oncogenes using flat revertants isolated from Kirsten sarcoma virus-transformed cells. In: G. F. Vande Woude, A. J. Levine, W. C. Topp, and J. D. Watson (eds.), Cancer Cells, 2: Oncogenes and Viral Genes, pp. 463–471. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1984.
52. Benade, L. E., Talbot, N., Tagliaferri, P., Hardy, C., Card, J., Noda, M., Najam, N., and Bassin, R. H. Ouabain sensitivity is linked to ras-transformation in human HOS cells. Biochem. Biophy. Res. Commun., 136: 807–814, 1986.